Accelerate your Drug Discovery
With our Proven, Integrated and Flexible Approach to Discovery Chemistry Solutions
Eurofins Discovery offers integrated discovery chemistry services that streamline the path from hit identification to IND-enabling studies. Our team of over 300 global experts in synthetic, medicinal, computational, and analytical chemistry delivers flexible, scalable, and scientifically rigorous solutions to support every stage of early drug development.
We combine AI-driven insights, high-throughput synthesis, cutting-edge automation and secure IP strategies to ensure quality, efficiency and innovation across all therapeutic modalities, including:
- Small molecules
- Peptides
- Antibody-drug conjugates (ADCs)
- Macrocycles
- Beyond Rule-of-5 (bRo5) candidates
Flexible Synthetic Chemistry for Every Stage
We support both Full-Time Equivalent (FTE) and Fee-For-Service (FFS) models, allowing for tailored engagement based on your project needs.
Benefit from:
- Array synthesis and reaction optimization
- Fully automated robotic synthesis
- High-throughput purification
- Integration with ADME & Rapid DMTA
Click to learn more about our full Synthetic Chemistry capabilities.
Optimized Medicinal Chemistry Services
Our global medicinal chemistry centres integrate ADME and biological profiling for rapid Design-Make-Test-Analyse (DMTA) cycles.
We provide:
- Innovative molecular design and IP generation
- Advanced modalities (PROTACs, molecular glues, macrocycles, Protein-Protein interaction modulators)
- Data-driven lead optimization and candidate selection using tools like Dotmatics, Vortex, DataWarrior, KNIME, PyMOL.
Click to learn more about our Medicinal Chemistry service capabilities.
Data-Driven Computational Chemistry
Our computational and medicinal chemistry teams excel in structure-based drug discovery, using molecular modelling, scaffold hopping, and chemo-informatics across all stages – from hit finding to lead optimization.
- Virtual Screening: Over 20 billion compounds screened via ligand- and structure-based methods (OpenEye), with docking, binding affinity prediction and lead hopping.
- AI/ML-based Computational Chemistry Workflows: Tools like DiscoveryAI SAFIRE (ADMET) and OPLE (off-targets), powered by our proprietary E dataset.
Click to learn more about our Data Driven Computational Chemistry service capabilities.
Advanced Analytical Chemistry for Quality and Compliance
Our state-of-the-art analytical labs provide rigorous compound characterization and support for CMC and IND-enabling requirements.
We specialise in:
- Detailed structural and purity analysis (using latest equipment and techniques e.g. NMR, LC-MS, HPLC, spectroscopy and GC)
- Co-located Rapid Scale-Up for Non-GMP Synthesis
- GMP Synthesis for IND-Enabling and Clinical Studies
- Solid-state characterization and stability studies
- Drug product development and impurity profiling
With operations across India, Spain, the US, and the UK, Eurofins Discovery offers unmatched expertise and global reach:
- 50+ drug candidates advanced to clinical trials
- 9 successfully launched drugs across over 11 validated target classes
- 230+ patents and 520+ scientific publications
- 50+ long-term biotech and pharma collaborations
With flexible engagement models and advanced technical capabilities, Eurofins Discovery helps you bring innovative therapies to patients – faster and more reliably.